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Abstract
Background and objectives Large-scale, contemporary studies exploring glomerular disease epidemiology in the
United States are lacking. We aimed to determine 30-year temporal and demographic trends in renal biopsy
glomerular disease diagnosis frequencies in the southeastern United States.
Design, setting, participants, &measurements In this cross-sectional, observational study,we identified all patients
with a native kidney biopsy specimen showing one of 18widely recognized glomerular disease diagnoses referred
to the University of North Carolina Chapel Hill Division of Nephropathology between 1986 and 2015. Biopsy era
(1986–1995, 1996–2005, and 2006–2015) and demographics (age, sex, and race) were our primary and secondary
predictors, respectively, and the relative frequency of each glomerular disease diagnosiswas our primary outcome.
Results Among 21,374 patients (mean age =48.3618.3 years old; 50.8% men; 56.8% white; 38.3% black; 2.8%
Latino; 1.4%Asian; 0.8% other), the frequency of diabetic glomerulosclerosis in renal biopsy specimens increased
dramatically over the three decades (5.5%, 11.4%, and 19.1% of diagnoses, respectively; P for trend,0.001). The
frequency of FSGS initially increased but then declined (22.6%, 27.2%, and 24.7%, respectively; P for trend =0.64).
The frequencies of other common glomerular disease subtypes remained stable (IgA nephropathy and ANCA/
pauci-immune GN) or declined (minimal change disease, membranous nephropathy, membranoproliferative
GN, and lupus nephritis). These temporal trends were largely preserved within all demographic subgroups,
although cross-sectional frequency distributions differed according to age, sex, and race.
Conclusions We identified significant changes in relative renal biopsy frequencies of many glomerular disease
subtypes over three decades. Temporal trends were consistently observedwithin all major demographic groups,
although relative predominance of individual glomerular disease subtypes differed according to patient age, sex,
and race. We propose that exploration of behavioral and environmental exposures that likely underlie these
findings should be the focus of future hypothesis-driven research.
Clin J Am Soc Nephrol 12: 614–623, 2017. doi: https://doi.org/10.2215/CJN.10871016
Introduction
Epidemiologic studies reveal important insights into
factors associated with glomerular disease develop-
ment or progression and inform predictions of the
relative likelihood of individual glomerular disease
diagnoses for a given patient. The disproportionally
high risks for FSGS in blacks and IgA nephropathy
in Asians encouraged the discovery of racially deter-
mined genetic risk variants (1,2). Associations between
population sanitation standards or socioeconomic sta-
tus and risks for certain GN subtypes suggest an etio-
logic role for environmental and lifestyle factors in
disease pathogenesis (3,4). Thus, identifying temporal
changes in glomerular disease epidemiology within a
geographic region might reliably inform future hypothesis-
driven studies and public health interventions.
Within the United States, prior studies exploring
glomerular disease epidemiology identified a marked
increase in the frequency of FSGS at the end of the 20th
century (5–9). Whether this trend continued into the
21st century has not been established, although a
small study (n=204) from Chicago suggested that
the frequency of FSGS (2000–2011) might now be
lower than that of membranous nephropathy among
blacks (10). Temporal trends are less consistent across
studies for other glomerular disease subtypes, ex-
plained by differences in population demographics
(e.g., white [9], military [11], or urban-dwelling pa-
tients [7]) or clinical inclusion criteria (e.g., nephrotic
syndrome [7,8] versus any glomerular disease [9,12]).
Frequencies of especially rare glomerular diseases are
seldom reported.
The Division of Nephropathology at the University
of North Carolina (UNC) at Chapel Hill has provided a
nephropathology service to the UNC and academic and
community practices throughout the southeastern
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United States since the 1970s. By examining native kidney
biopsy cases from patients submitted between 1986 and
2015, we aimed to describe temporal trends in glomerular
disease frequencies over three decades and explore the
influence of demographic factors on glomerular disease
frequency distributions.
Materials and Methods
Patient Population
All native kidney biopsy specimens referred to the
Division of Nephropathology at the UNC (1986–2015)
with one of 18 widely recognized diagnostic categories
of glomerular disease were considered for study inclusion.
The referral population was derived predominantly from
residents of North Carolina and its neighboring states, in-
cluding Virginia, West Virginia, Tennessee, South Caro-
lina, and Georgia. If a patient had multiple biopsies
with a glomerular disease diagnosis, only the first was
retained for this study. If more than one glomerular dis-
ease diagnosis was made from a single biopsy specimen,
that which seemed to be the major cause for the renal
dysfunction prompting the biopsy was chosen as the study
diagnosis (i.e., if the primary diagnosis was a glomerular
disease, then we retained this diagnosis; otherwise, we
searched for the presence of a glomerular disease as a sec-
ondary diagnosis, such that a single predominant glomer-
ular disease was elucidated for each patient).
Data Source
All renal biopsy specimens were processed by standard
light, immunofluorescence, and electron microscopy pro-
cedures. Diagnoses were those made by experienced
nephropathologists involved in the clinical care of patients.
For analysis, all Columbia variants of FSGS (13), all Ehren-
reich and Churg stages of membranous nephropathy (14),
and all International Society of Nephrology/Renal Pathol-
ogy Society classes of lupus nephritis (15) were grouped
into respective FSGS, membranous nephropathy, and lu-
pus nephritis categories. Dense deposit disease (membra-
noproliferative GN [MPGN] type 2) was analyzed
separately from other forms of MPGN. Immune complex
MPGN and C3 GN with an MPGN pattern of injury (in-
cluding so-called types 1 and 3 MPGN) were included in
the MPGN category, because the distinction between these
two disease entities was only recently recognized (16). The
uncommon C1q and IgM mesangial nephropathies were
subsumed in minimal change disease and FSGS categories
on the basis of the light microscopic pattern of injury. A
diagnosis of pauci-immune necrotizing and crescentic GN
was on the basis of pathologic phenotype without requir-
ing serologic ANCA positivity. Antiglomerular basement
membrane GN that was also ANCA positive was included
in the antiglomerular basement membrane GN category.
Demographic data were abstracted from biopsy referral
forms completed by referring nephrologists or available
medical records.
Exposures, Outcomes, and Covariates
Temporal era was our primary exposure, categorized in
to three consecutive 10-year time intervals (1986–1995,
1996–2005, and 2006–2015) for tabular presentation and
data analysis and six consecutive 5-year time intervals
(1986–1990, 1991–1995, 1996–2000, 2001–2005, 2006–2010,
and 2011–2015) for plotting. Glomerular disease subtype
frequency was our primary outcome. As secondary out-
comes, we also examined temporal trends in glomerular
disease frequencies within demographic subgroups as well
as by typical mode of clinical presentation for a given sub-
type (nephrotic versus nephritic syndrome [17]). To ex-
plore combined influences of age, sex, and race, we
evaluated glomerular disease frequency distributions
across age categories stratified by patient sex and race.
Statistical Analyses
Categorical variables were expressed as frequencies
(percentages) and compared using chi-squared or Fisher
exact testing as appropriate. When analyzing differences
across study eras, P for trend values are reported. Contin-
uous variables were expressed as means (SDs) or medians
(interquartile ranges) and compared using ANOVA or
Kruskall–Wallis testing as appropriate. Statistical analyses
were performed using SAS Enterprise Guide, version 6.1
(SAS, Cary, NC). A two-sided P value of ,0.05 was con-
sidered statistically significant when analyzing demo-
graphic data, and a Bonferroni correction for multiple
comparisons (0.05/18=0.0027) was applied when analyz-
ing trends across 18 glomerular disease subtypes.
Institutional review board (IRB) approval for the study
was obtained from the UNC Biomedical IRB (Study 97–0523).
Results
Patient Population
In total, 38,472 kidney biopsies (33,391 native and 5081
transplant) were evaluated between 1986 and 2015. Biopsy
frequencies increased annually from 390 (1986) to 1923 (2015).
Of these, 22,516 native kidney specimens had one of the 18
study diagnoses. From these, 1142 repeat biopsies in 1016
patients were excluded, leaving a final study population of
21,374 patientswith one of the 18 glomerular disease subtypes
of interest diagnosed on an initial native kidney biopsy.
Average patient age was 48.3 (618.3) years old, 50.8%
were men, 56.8% were white, and 38.3% were black (Table
1). With each consecutive decade, patients were older at
the time of biopsy (mean age =45.1619.1, 46.9618.2, and
50.4617.9 years old, respectively; P,0.001). The largest
number of specimens (54.4% of all samples with a docu-
mented state of origin) was received from centers in North
Carolina, whereas most of the remaining specimens
(42.5%) came from other southeastern states, including
Georgia, South Carolina, Tennessee, and Virginia (Supple-
mental Table 1). The demographics of our study cohort
were compared with those of the population of North Car-
olina. Percentage of men in our cohort was similar to that
reported for North Carolina in the 2010 Census (51% men)
(18) and did not change significantly over time. Black race
was more prevalent in our cohort (38%) than at the state
level (22%), whereas white race (57% versus 69%, respec-
tively), Latino ethnicity (3% versus 8%, respectively), and
Asian race (1% versus 2%, respectively) were less preva-
lent. In both populations, Asian race and Latino ethnicity
increased over time, whereas white race declined, and
black race remained stable.
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Temporal Trends in Glomerular Disease Frequency
Renal biopsy frequencies by study era and glomerular
disease subtype are provided in Figure 1 and Table 2. In
the earliest era (1986–1995), FSGS predominated (22.6% of
studied patients) followed by membranous nephropathy
(17.8%). In the middle (1996–2005) and later (2006–2015)
eras, FSGS still predominated (27.2% and 24.7%, respec-
tively) but was followed by lupus nephritis (13.9%) and
Table 1. Temporal trends in patient demographics among the study cohort of patients with specified glomerular disease diagnoses
Demographic
Characteristics
1986–1995,
n=3257
1996–2005,
n=7954
2006–2015,
n=10,163
Total,
n=21,374 PValue
Age, mean (SD) 45.1 (19.1) 46.9 (18.2) 50.4 (17.9) 48.3 (18.3) ,0.001
Age category, yr, % (n) ,0.001
0–17 8.3 (265) 5.3 (417) 3.3 (334) 4.8 (1016)
18–39 32.0 (1020) 30.6 (2415) 24.8 (2518) 28.0 (5953)
40–64 40.2 (1282) 44.5 (3515) 47.0 (4772) 45.1 (9569)
.64 19.6 (624) 19.6 (1547) 24.9 (2525) 22.1 (4696)
Missing age, % 2.0 0.8 0.1 0.7
Men, % (n) 51.9 (1689) 50.1 (3949) 51.1 (5185) 50.8 (10,823) 0.17
Missing sex, % 0.1 0.8 0.1 0.3
Race, % (n) ,0.001
White 64.1 (1610) 56.6 (3782) 54.7 (4714) 56.8 (10,106)
Black 34.5 (867) 39.9 (2662) 38.2 (3292) 38.3 (6821)
Latino 0.6 (14) 1.8 (123) 4.2 (360) 2.8 (497)
Asian 0.0 (1) 1.0 (69) 2.0 (170) 1.4 (240)
Other 0.8 (19) 0.6 (42) 0.9 (81) 0.8 (142)
Missing race % 22.9 16.0 15.2 16.7
Percentages (except missing percentages) represent column percentages among patients with complete data.
Figure 1. | Temporal trends in the relative renal biopsy frequencies of the most common glomerular disease subtypes, 1986–2015. (A)
Frequencies of the eight most common glomerular disease subtypes shown as a proportion of the entire cohort. (B) Frequencies of the seven
most common glomerular disease subtypes shown as a proportion of remaining subtypes after excluding diabetic glomerulosclerosis (GS).
IgAN, IgA nephropathy; MPGN, membranoproliferative GN excluding dense deposit disease.
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membranous nephropathy (13.8%) in the middle era and
diabetic glomerulosclerosis (19.1%) in the most recent era.
Significant temporal changes in glomerular disease sub-
type relative frequencies were observed (Figure 1, Table 2).
Most notable was a steady increase in the frequency of
diabetic glomerulosclerosis over the three study decades
(5.5%, 11.4%, and 19.1% of diagnoses, respectively; P for
trend ,0.001). The frequency of FSGS increased initially,
but then, it plateaued and ultimately declined (22.6%,
27.2%, and 24.7%, respectively; P=0.64). The frequencies
of membranous nephropathy (17.8%, 13.8%, and 10.6%,
respectively; P,0.001) and minimal change disease
(8.8%, 5.5%, and 4.1%, respectively; P,0.001) declined
substantially over the study interval, whereas those of lu-
pus nephritis (12.8%, 13.9%, and 11.2%, respectively;
P,0.001) and MPGN types 1 or 3 (4.5%, 2.9%, and 2.5%,
respectively; P,0.001) declined more modestly. The fre-
quencies of IgA nephropathy (10.2%, 11.4%, and 9.4%;
P=0.004) and ANCA/pauci-immune GN (9.3%, 6.8%,
and 8.3%; P=0.14) remained stable. As a sensitivity analy-
sis, we re-examined the frequencies of remaining subtypes
after excluding diabetic glomerulosclerosis to ensure that
large shifts in the frequency of this diagnosis did not un-
duly influence frequency distributions among the remain-
ing 17 subtypes. Findings were not materially different
(Figure 1B).
Among more rare subtypes (biopsy frequency ,3%),
some significant temporal trends were also observed (Ta-
ble 2). Significant increases were observed in thin base-
ment membrane lesion and monoclonal Ig deposition
disease frequencies.
Temporal Trends in Glomerular Disease Frequencies by
Age, Sex, and Race
Temporal trends in men or women mirrored those in the
overall cohort (Supplemental Figure 1). However, differ-
ences between sexes were observed at a cross-sectional
level. For example, lupus nephritis was more frequent in
women than men (20.5% versus 4.7%, respectively),
whereas the opposite was true for IgA nephropathy
(7.7% versus 12.8%, respectively). Sex distributions by glo-
merular disease subtype are shown in Supplemental Fig-
ure 2 and Table 3.
For black or white patients, temporal trends were also
similar to those observed in the full cohort (Supplemental
Figure 1). Comparing races cross-sectionally, however, lu-
pus nephritis (20.9% versus 6.3%, respectively) and FSGS
(33.6% versus 20.4%, respectively) were more frequent and
IgAN (2.3% versus 14.9%, respectively) and ANCA/pauci-
immune GN (3.3% versus 11.4%, respectively) less fre-
quent among blacks. Racial distributions, by subtype, are
presented in Supplemental Figure 2 and Table 3.
Table 2. Temporal trends in the renal biopsy frequencies of glomerular disease subtypes among the study cohort of patients with
specified glomerular disease diagnoses
Glomerular disease
subtype
1986–1995,
n=3257
1996–2005,
n=7954
2006–2015,
n=10,163
Total,
n=21,374
Nephrotic subtypes
FSGS 22.6 (737) 27.2 (2165) 24.7 (2506) 25.3 (5408)
Diabetic glomerulosclerosisa 5.5 (179) 11.4 (903) 19.1 (1942) 14.2 (3024)
Membranous nephropathya 17.8 (579) 13.8 (1097) 10.6 (1078) 12.9 (2754)
Minimal change diseasea 8.8 (286) 5.5 (441) 4.1 (415) 5.3 (1142)
MPGNa 4.5 (145) 2.9 (233) 2.5 (256) 3.0 (634)
Amyloidosis 2.2 (73) 2.0 (158) 2.5 (252) 2.3 (483)
MIDDa 0.6 (20) 0.6 (51) 1.6 (160) 1.1 (231)
Dense deposit disease 0.3 (8) 0.1 (9) 0.2 (22) 0.2 (39)
Fabry diseaseb 0.1 (3) 0.1 (11) 0.0 (2) 0.1 (16)
Collagenofibrotic
glomerulopathy
0.1 (2) 0.0 (2) 0.0 (1) 0.0 (5)
Total 62.4 (2032) 63.7 (5070) 65.3 (6634) 64.3 (13,736)
Nephritic subtypes
Lupus nephritisa 12.8 (416) 13.9 (1109) 11.2 (1142) 12.5 (2667)
IgANc 10.2 (332) 11.4 (908) 9.4 (958) 10.3 (2198)
ANCA/pauci-immune GN 9.3 (304) 6.8 (540) 8.3 (846) 7.9 (1690)
TBM lesiona 1.9 (63) 1.3 (101) 3.0 (304) 2.2 (468)
Fibrillary GN 1.5 (48) 1.2 (99) 1.4 (141) 1.4 (288)
Anti-GBM nephritisc 1.1 (37) 1.0 (82) 0.8 (77) 0.9 (196)
Alport syndrome 0.6 (20) 0.4 (35) 0.5 (50) 0.5 (105)
Immunotactoid GN 0.2 (5) 0.1 (10) 0.1 (11) 0.1 (26)
Total 37.6 (1225) 36.3 (2884) 34.7 (3529) 35.7 (7638)
All values represent column percentages (n). MPGN, membranoproliferative GN (nondense deposit disease); MIDD, monoclonal
immune deposition disease; IgAN, IgA nephropathy; TBM, thin basement membrane; GBM, glomerular basement membrane.
aChi-squared test for trend, P,0.003.
bFisher exact test, P,0.05 but P.0.003.
cChi-squared test for trend, P,0.05 but P.0.003.
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Temporal trends by age category (children, young
adults, middle-aged adults, and older adults) are also
presented in Supplemental Figure 1. Again, no marked
deviations from overall trends were observed, with the
exception of a low frequency of diabetic glomerulosclero-
sis in children. However, cross-sectional differences were
again apparent; lupus nephritis was almost as common as
FSGS in young adults (25.7% versus 27.3%, respectively)
but rare in older adults (2.2%), whereas ANCA/pauci-im-
mune GN was especially frequent in older adults (17.9%)
but rare in children (3.9%) and young adults (2.7%). Av-
erage ages by glomerular disease subtype are shown in
Table 3.
Differences in Glomerular Disease Frequencies by Age
Category, Sex, and Race
To further explore the variations in disease frequencies
observed between age groups, we examined changes in
glomerular disease frequencies across the age spectrum
(Figures 2 and 3). Very young (0–9 years old) patients were
most likely to have minimal change disease, very old (.79
years old) patients were most likely to have ANCA/pauci-
immune GN, and younger or middle-aged adults were
most likely to have FSGS. Stratifying by sex and race re-
vealed additional insights; for example, IgAN was most
frequent in young adult white men, whereas lupus nephri-
tis peaked in young adult black women.
When glomerular disease subtype frequencies were
evaluated as a proportion of all glomerular disease diag-
noses in a given age group, the predominance of certain
subtypes within particular age groups became even more
apparent (Figure 4). Among patients typically presenting
with nephrotic syndrome, the likelihood of a renal biopsy
diagnosis of minimal change disease declined precipi-
tously after early childhood, whereas diabetic
glomerulosclerosis was less likely to be diagnosed in older
patients, and FSGS was frequent throughout. Among pa-
tients typically presenting with nephritic features, the
likelihood of IgA nephropathy declined with advancing
age, lupus nephritis peaked in young adulthood, and
ANCA/pauci-immune GN was strikingly common in
older adults.
Discussion
In this study of 21,374 patients with a biopsy-confirmed
glomerular disease diagnosis residing predominantly in
the southeastern United States, we identified significant
temporal shifts in the epidemiology of many glomerular
disease subtypes over the past three decades (1986–2105).
Most striking was a marked increase in renal biopsy fre-
quency of diabetic glomerulosclerosis from 5.5% of pa-
tients in the earliest decade to 19.1% of patients most
recently. This finding was consistently observed within
all studied age, sex, and racial groups, with the exception
of children. Contemporaneously, we observed an initial
increase in frequency of FSGS at the end of the 20th cen-
tury, as previously reported in other United States cohorts
(5–9), followed by a plateau and decline in its frequency
more recently, a finding not previously described. At the
same time, we observed significant declines in relative fre-
quencies of some other glomerular disease subtypes (e.g.,
membranous nephropathy, minimal change disease, mem-
branoproliferative GN [excluding dense deposit disease],
and lupus nephritis) along with stable frequencies of oth-
ers (e.g., IgA nephropathy and ANCA/pauci-immune
GN). These temporal trends were not explained by large
shifts in the demographic composition of our study pop-
ulation and were consistently observed in most age, sex,
and racial subgroups.
Figure 2. | Absolute renalbiopsydiagnosis frequencies of themost commonglomerular disease subtypes according topatient agecategory. (A)All
subtypes: number of patients with each of the eight most common glomerular disease subtypes shown. (B) Nephrotic subtypes: number of patients
with each of the eight most common glomerular disease subtypes that often present with nephrotic syndrome shown (Fabry disease and collage-
nofibrotic glomerulopathy not shown). (C) Nephritic subtypes: number of patients with each of the eight glomerular disease subtypes that often
present clinically with nephritic features shown. DDD, dense deposit disease; GBM, glomerular basement membrane; GS, glomerulosclerosis;
IgAN, IgA nephropathy; MIDD, monoclonal immune deposition disease; MPGN, membranoproliferative GN; TBM, thin basement membrane.
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Interpretation of our study is complicated by the steadily
increasing biopsy referral rate to the UNC over the study
interval. Although we report trends in relative disease
frequencies (i.e., as a proportion of all biopsies with a glo-
merular disease diagnosis), we note that, in some cases, a
decline in relative disease frequency was accompanied by
an increase in absolute disease frequency. The underlying
reasons for the rising background biopsy rate may include
(1) a declining threshold to biopsy patients; (2) an increase
in the referral population size, mirroring that occurring in
North Carolina (19,20); (3) increasing numbers of nephrol-
ogists referring biopsies to the UNC; or (4) true increases
in disease incidence. This latter possibility is supported by
the fact that diseases with a stronger environmental/life-
style component to their pathogenesis (e.g., FSGS and di-
abetic glomerulosclerosis) underwent more marked
increases in disease frequency than those with a more
clearly established genetic or autoimmune pathogenesis
(e.g., ANCA/pauci-immune GN or IgA nephropathy). It
is notable that, for some glomerular disease subtypes (e.g.,
membranous nephropathy or minimal change disease), the
absolute numbers of patients declined in the final decade,
supporting a true decline in disease incidence. Conversely,
the rising frequency of diabetic glomerulosclerosis mark-
edly exceeded the increasing background biopsy referral
rate, supporting a true increase in the incidence of this
biopsy diagnosis and echoing findings from the general
population that the incidence of diabetes mellitus has in-
creased almost twofold between 1995 and 2010 (21).
In an effort to disentangle the influence of shifts in
population demographics from that of changes in envi-
ronmental, lifestyle, or practice pattern factors, we evalu-
ated for temporal changes in the sex, age, or racial
composition of our study cohort in addition to examining
temporal trends in glomerular disease frequencies within
several demographic subgroups. In summary, we did not
identify convincing evidence that demographic shifts in
our study population were responsible for the changes in
glomerular disease frequencies that we observed and
suggest that changes in lifestyle/environmental factors
or clinical practice are more likely to underlie our findings.
Compared with prior studies exploring glomerular
disease epidemiology in the United States, our study has
some notable differences. First, white and black races were
both well represented in our cohort, differing from studies
that focused almost exclusively on white patients (9). Sec-
ond, we included all age groups, unlike studies focusing
only on adults (12,22). Third, we examined systemic cau-
ses of glomerular disease (e.g., lupus nephritis, ANCA/
pauci-immune GN, and diabetic glomerulosclerosis) in ad-
dition to so-called primary glomerular diseases to
capture a wide spectrum of patients undergoing kidney
Male Female 
White Black 
Figure 3. | Absolute renal biopsy diagnosis frequencies of the most common glomerular disease subtypes according to patient age category
stratified by sex and race. GS, glomerulosclerosis; IgAN, IgA nephropathy; MPGN, membranoproliferative GN.
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biopsy for evaluation of suspected glomerular disease.
This differs from prior studies limited to patients with ne-
phrotic syndrome (7,8), proteinuria in excess of 2 g/24 h
(5), or a more restricted set of primary glomerular disease
diagnoses (6,8,22,23). Both of the prior studies that
included a wide spectrum of primary and secondary glo-
merular diseases (9,12) excluded patients with diabetic glo-
merulosclerosis, prompting our decision to analyze our data
with and without diabetic glomerulosclerosis to facilitate
comparisons with these studies (our conclusions were unal-
tered). Fourth, our study is the largest and most contempo-
rary to date; with the exception of two much smaller studies
published earlier this year (12,22), recent reports of United
States glomerular disease epidemiology are lacking.
Despite these differences, many of our findings support
those previously reported. The marked increase in FSGS
frequency previously identified at the end of the 20th
century (5–9), particularly among blacks, was again seen in
our patient cohort. However, our study is the first to
show a plateau and subsequent decline in FSGS frequency
more recently; unlike a smaller study (n=204) that
reported a predominance of membranous nephropathy
over FSGS among all racial groups in a contemporary
(2001–2011) patient cohort (10), FSGS remained the most
frequent glomerular disease subtype in all racial groups in
our study. Whether the recent decline in FSGS frequency
represents a reduction in patients with primary/idiopathic
cases, patients with secondary (e.g., obesity-related) cases,
or the likelihood to biopsy a patient with proteinuria could
not be discerned from our data.
The rapid and steady increase in the frequency of
diabetic glomerulosclerosis that we observed has not, to
our knowledge, previously been reported. We propose that
this finding largely reflects a true increase in disease
incidence, mirroring the increase in diabetes mellitus in-
cidence observed in the United States over the same time
interval (24). Additionally, an increasing tendency to bi-
opsy older patients or search for nondiabetic glomerular
diseases among patients with diabetes (25,26) might un-
derlie these findings.
Considering other glomerular disease subtypes, the
declining frequency of membranous nephropathy that
we observed was reported by some (5) but not all (7–
9,22) prior studies, whereas a stable frequency of IgA ne-
phropathy (5,8,9) and declining frequency of minimal
change disease (7–9,22) have more consistently been ob-
served. With respect to the declining frequency of minimal
change disease, pediatric nephrologists might be more in-
clined to empirically treat children with nephrotic syn-
drome, obviating the need for a kidney biopsy, in more
recent decades; however, this would not explain the de-
cline in minimal change disease frequency in middle-aged
and older adults. With respect to the declining frequency
of membranous nephropathy, we do not expect that test-
ing for antiphospholipase A2 receptor antibodies has yet
replaced the role of kidney biopsy in this disease group.
Figure 4. | Relative renal biopsy diagnosis frequencies of the most common glomerular disease subtypes according to patient age category
and typical mode of clinical presentation. (A) nephrotic syndrome; (B) nephritic features. DDD, dense deposit disease; GBM, glomerular
basement membrane; GS, glomerulosclerosis; IgAN, IgA nephropathy; MIDD, monoclonal immune deposition disease; MPGN, mem-
branoproliferative GN; TBM, thin basement membrane.
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Thus, we consider declines in the relative frequencies of these
diagnoses to be most likely due to true declines in disease
incidence. Descriptions of temporal trends in several more
rare glomerular disease subtypes are also novel to our study.
In addition to reporting temporal trends, we also confirm
some previously described demographic predispositions to
glomerular disease development (e.g., a higher risk for IgA
nephropathy in younger white or Asian patients [23] and a
higher risk for lupus nephritis in younger black patients or
women [27]) in a large and contemporary United States
cohort. We also comprehensively analyzed glomerular dis-
ease frequencies according to several combinations of de-
mographic factors and typical modes of glomerular
disease presentation (nephrotic versus nephritic), which
may serve as useful resources to clinicians evaluating pa-
tients in the clinic or researchers aiming to target high-risk
patient groups for inclusion in future translational re-
search studies or interventional trials.
Our study has several limitations. We had too few Latino
and Asian patients to enable analysis of temporal trends or
demographic associations in these racial/ethnic groups.
We could not precisely determine our referral population
size and thus, report relative (not absolute) incidences. We
estimate that the Division of Nephropathology at the UNC
biopsies derive from a population of approximately 10
million people, although accurate estimates of population
sizes over time could not be determined.
To conclude, we identified in a large, contemporary
United States population that the frequencies of many
glomerular disease subtypes have shifted considerably
over the past three decades. We provide evidence that
changes in population demographics (age, sex, or race)
contributed minimally to these findings and instead, pro-
pose that environmental and lifestyle changes most likely
underlie them. Of particular concern was the dramatic
increase in the frequency of diabetic glomerulosclerosis
that we observed given the adverse outcomes (28) and in-
creased health care costs (29) associated with this diabetic
complication. On a more encouraging note, the relative
(and in some cases, absolute) frequencies of some other
glomerular disease subtypes declined. We propose that
further exploration of the underlying reasons for these ep-
idemiologic shifts is warranted and that these efforts
might reveal novel insights into disease pathogenesis or
therapeutic opportunities.
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